Ping An’s Voyager brings good health to PE
Euromoney, is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
CAPITAL MARKETS

Ping An’s Voyager brings good health to PE

The fund is deploying $1 billion of the Chinese group’s money into digital medicine and fintech around the world, but profit is not its main ambition.

jonathan larsen 780x400

Jonathan Larsen, Ping An



In the increasingly crowded field of home-grown Chinese private equity and venture capital, one member of the throng is doing its own thing. Ping An Global Voyager is a $1 billion fund whose number-one priority is not its returns. 

“I’m not going to be a very popular fellow if we don’t deliver a reasonable return on Ping An and [founder] Peter Ma’s dollars,” says Jonathan Larsen, chairman and chief executive of the fund and chief innovation officer across the whole Ping An group. “But financial return is not the primary criteria. The objective is much more than that.”

Instead, Larsen says, the objective is “a way of extending Ping An’s access to capabilities.” 

It is principally about buying its way into emerging innovation outside China and bringing that expertise back for the group to assimilate and build upon. 

“We do a lot of internal R&D, but there is an enormous amount of innovation going on, in fintech and digital health in particular,” he says. 

Those two fields are the priority of the fund, which launched last year with $1 billion to deploy.  




Gift this article